HIPAAHealth Insurance Portability and Accountability Act
HIPAA — the Health Insurance Portability and Accountability Act of 1996, plus the HITECH Act of 2009 and the Omnibus Rule of 2013 — governs the use and disclosure of Protected Health Information (PHI) by Covered Entities (health plans, healthcare clearinghouses, healthcare providers who transmit electronically) and their Business Associates. Pure pharma, supplement and food manufacturers rarely fall in scope. Radiopharmaceutical sites that handle patient identifiers (unit-dose dispense to a named patient) typically need a Business Associate Agreement (BAA) with the receiving hospital.
01What HIPAA does
HIPAA establishes federal standards in the US for the protection of individually identifiable health information. The 1996 statute set the architecture; subsequent rules (Privacy Rule 2000, Security Rule 2003, Enforcement Rule 2006, Breach Notification Rule 2009, Omnibus Rule 2013) operationalised it. HITECH 2009 extended direct enforcement to Business Associates and introduced breach-notification timelines. OCR within HHS enforces, with civil penalties up to USD 1.5 million per violation category per year and the possibility of criminal referral.
02Who HIPAA applies to
- Covered Entities — health plans (insurers), healthcare clearinghouses, and healthcare providers who transmit any health information electronically in connection with a HIPAA-covered transaction. The provider category includes hospitals, physicians, dentists, pharmacies, nursing homes, home-health agencies and many others.
- Business Associates — persons or entities that create, receive, maintain or transmit PHI on behalf of a covered entity to perform a function or activity regulated by HIPAA. Examples: cloud-hosting providers holding ePHI, claims-processing vendors, IT MSPs with PHI access, pharmacovigilance vendors, radiopharmaceutical dispensing services, certain MES/QMS vendors when their system holds patient-linked data.
- Subcontractors of Business Associates — flow-down obligations apply via written agreements.
Pure pharma, food, supplement, cosmetic and medical-device manufacturers without patient-identified data rarely meet the test. The boundary becomes real when patient identifiers cross the manufacturer's systems — for example, a radiopharmacy preparing a unit-dose syringe labelled with a named patient on the hospital's order, or a medical-device manufacturer's connected-device cloud that receives patient-identified telemetry.
03PHI and ePHI — what counts
Protected Health Information (PHI) is individually identifiable health information transmitted or maintained in any form (paper, oral, electronic). ePHI is the electronic subset. "Individually identifiable" is the key qualifier — and the 18 HIPAA identifiers go well beyond name and date of birth:
- Names; geographic subdivisions smaller than state; all dates (except year) directly related to an individual; phone numbers; fax numbers; email addresses; SSN; medical record numbers; health plan beneficiary numbers; account numbers; certificate/licence numbers; vehicle identifiers; device identifiers and serial numbers; URLs; IP addresses; biometric identifiers; full-face photographs; and any other unique identifying number, characteristic or code.
De-identification under the Safe Harbor method requires removal of all 18 identifiers; under the Expert Determination method, a qualified statistician must conclude the risk of re-identification is very small.
04Privacy Rule — uses and disclosures
The Privacy Rule (45 CFR 164 Subparts A + E) limits PHI use and disclosure to:
- Treatment, payment and healthcare operations (TPO) — broad permitted use without authorisation.
- Public-interest activities (public health, law enforcement, judicial proceedings, etc.) — narrowly defined with conditions.
- Patient authorisation — explicit, written, time-bounded, revocable.
- Limited datasets and de-identified data — special handling permitted with data-use agreements where applicable.
The Minimum Necessary rule applies to almost everything outside TPO — only the smallest PHI subset required for the purpose may be used or disclosed. Patients have rights to access their PHI, request amendments, receive an accounting of disclosures, and request restrictions.
05Security Rule — administrative, physical, technical safeguards
The Security Rule (45 CFR 164 Subpart C) is specifically about ePHI. It is technology-neutral and risk-based, with required and "addressable" implementation specifications across three safeguard categories:
- Administrative — security management process, risk analysis, risk management, workforce training, contingency planning, periodic evaluation, BAAs.
- Physical — facility access controls, workstation security, device and media controls (encryption, disposal).
- Technical — access control (unique user ID, emergency access, automatic logoff, encryption + decryption), audit controls, integrity, person/entity authentication, transmission security.
NIST SP 800-66 Rev. 2 (Feb 2024) is the canonical practitioner reference for implementing the Security Rule — it maps each implementation specification to NIST SP 800-53 / Cybersecurity Framework controls so a covered entity can demonstrate alignment with both regimes simultaneously.
06Breach Notification Rule
Following an unauthorised acquisition, access, use or disclosure of unsecured PHI, the covered entity must notify:
- Affected individuals — without unreasonable delay and in no case later than 60 calendar days from discovery.
- HHS Secretary — within 60 days if 500+ individuals affected; annually otherwise.
- Prominent media outlets — if 500+ individuals in a state or jurisdiction.
- Business Associates must notify the Covered Entity without unreasonable delay (no later than 60 days).
A risk assessment determines whether unauthorised disclosure constitutes a breach; encryption per HHS-recognised standards renders PHI "unsecured" exempt from breach notification.
07Business Associate Agreements (BAAs)
A BAA is the contractual instrument that flows HIPAA obligations from a Covered Entity to a Business Associate (and from Business Associate to subcontractor). 45 CFR 164.504(e) prescribes the required content: permitted uses and disclosures, safeguards, breach reporting, subcontractor flow-down, individual rights support, HHS access, termination and return / destruction of PHI.
08HIPAA vs 21 CFR Part 11
HIPAA and Part 11 are commonly confused. They are distinct:
- HIPAA — protects patient health information (privacy + security). Enforced by HHS OCR. Applies to covered entities and business associates.
- Part 11 — establishes criteria for electronic records and electronic signatures used to satisfy FDA regulations (e.g. batch records, complaint files, design history files). Enforced by FDA. Applies to FDA-regulated industry.
A single system can be subject to both — for example, a radiopharmacy MES that issues GMP-regulated batch records (Part 11) and holds patient identifiers on the unit-dose label (HIPAA). The control sets overlap (audit trail, access control, encryption) but the legal bases are independent.
09Common mistakes
- Treating any cloud system as automatically HIPAA-compliant — no system is HIPAA-compliant in isolation; the BAA + the customer's controls + the vendor's controls together compose compliance.
- Skipping de-identification analysis when sharing "anonymised" data — Safe Harbor requires all 18 identifiers removed; Expert Determination requires statistical evidence.
- BAA missing for cloud hosting, IT MSP, third-party support, courier — any vendor with PHI access needs one.
- Encryption assumed but not implemented to HHS-recognised standards — only specific cryptographic standards qualify PHI as "unsecured".
- Workforce training not refreshed annually.
- Breach risk-assessment shortcut to "low risk of compromise" without documented analysis.
- Failure to separate Part 11 audit-trail expectations from HIPAA access-log expectations — both required, different content.
10How V5 Ultimate handles HIPAA
Frequently asked questions
Q.Is my pharma manufacturing site subject to HIPAA?+
If patient-identified data does not cross your systems, no. The moment a workflow handles patient identifiers (radiopharmacy unit-dose labelling, connected-device telemetry, pharmacovigilance case data with identifiers), HIPAA applies and a BAA is usually needed.
Q.Is HIPAA the same as Part 11?+
No — HIPAA protects patient health information; Part 11 governs FDA-regulated electronic records and signatures. Both can apply to the same system, with overlapping but distinct controls.
Q.Does encryption avoid breach notification?+
Yes — PHI encrypted to HHS-recognised standards is "secured" and outside the Breach Notification Rule scope. Encryption to other standards or with poor key management does not qualify.
Q.Are cloud providers HIPAA-compliant?+
Cloud providers can sign BAAs and provide HIPAA-eligible services, but no provider is HIPAA-compliant in isolation. Compliance depends on the BAA + provider controls + customer-side configuration + workforce training together.
Q.What's the penalty for a HIPAA violation?+
Civil penalties range from USD 100 to USD 50,000 per violation depending on culpability tier, capped at USD 1.5 million per violation category per year. Wilful neglect cases can also lead to criminal prosecution.
Primary sources
- 45 CFR Part 160 — General Administrative Requirements
- 45 CFR Part 162 — Administrative Requirements
- 45 CFR Part 164 — Security and Privacy
- HHS OCR — HIPAA for Professionals
- HITECH Act (Title XIII, ARRA 2009) — breach notification, BA direct liability
- NIST SP 800-66 Rev. 2 (2024) — Implementing the HIPAA Security Rule
Further reading
Explore this topic
HIPAA sits inside this topic cluster in our glossary. Every neighbour is one click away.
Electronic records, signatures, audit trail and ALCOA+ data-integrity principles.
V5 Ultimate ships with the HIPAA controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.
